Applied dna to report fiscal 2022 fourth quarter and year end financial results on december 14, 2022

Stony brook, n.y.--( business wire )--applied dna sciences, inc. (nasdaq: apdn) (the “company”), a leader in pcr-based dna technologies, today announced that it plans to release its fiscal 2022 fourth quarter and year-end financial results after the market close on wednesday, december 14, 2022.

APDN Ratings Summary

APDN Quant Ranking